Literature DB >> 26255648

Metabolic reprogramming of the tumour microenvironment.

Yazhi Xing1, Shimin Zhao2, Binhua P Zhou3, Jun Mi1.   

Abstract

Tumour cells, stromal cells and the stroma comprise the tumour microenvironment. The metabolism of both tumour cells and several types of tumour stromal cells, such as cancer-associated fibroblasts and tumour-associated macrophages, is reprogrammed. Current studies have found that stromal cells promote tumour progression and metastasis, through not only the paracrine secretion of cytokines or chemokines, but also intermediate metabolites. Here, we summarize the latest insights into the mechanism of metabolic reprogramming in cancer cells, cancer-associated fibroblasts and tumour-associated macrophages, and their potential roles in tumour progression and metastasis.
© 2015 FEBS.

Entities:  

Keywords:  Aerobic glycolysis; Warburg effect; cancer-associated fibroblast; epigenetic regulation; metabolic reprogramming; metabolites shuttling; oxidative phosphorylation; tumor progression; tumour microenvironment; tumour-associated macrophage

Mesh:

Year:  2015        PMID: 26255648     DOI: 10.1111/febs.13402

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  33 in total

Review 1.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

Review 3.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

4.  Cell proliferation downregulated by TGF-β2-triggered G1/S checkpoint in clinical CAFs.

Authors:  Jinliang Wu; Rong Fu; Zongzhi Liu; Guochao Li; Xiaolei Huang; Yang Xue; Yan Xu; Yingli Sun; Jiangmin Zhao; Jun Mi
Journal:  Cell Cycle       Date:  2016-11-23       Impact factor: 4.534

Review 5.  Tumor microenvironment promotes breast cancer chemoresistance.

Authors:  Umar Mehraj; Abid Hamid Dar; Nissar A Wani; Manzoor A Mir
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-09       Impact factor: 3.333

Review 6.  DNA methylation in the tumor microenvironment.

Authors:  Meng-Wen Zhang; Kenji Fujiwara; Xu Che; Shu Zheng; Lei Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2017-05       Impact factor: 3.066

7.  Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.

Authors:  Yana G Najjar; Ashley V Menk; Cindy Sander; Uma Rao; Arivarasan Karunamurthy; Roma Bhatia; Shuyan Zhai; John M Kirkwood; Greg M Delgoffe
Journal:  JCI Insight       Date:  2019-03-07

8.  Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma.

Authors:  Angela Riedel; Moutaz Helal; Luisa Pedro; Jonathan J Swietlik; David Shorthouse; Werner Schmitz; Lisa Haas; Timothy Young; Ana S H da Costa; Sarah Davidson; Pranjali Bhandare; Elmar Wolf; Benjamin A Hall; Christian Frezza; Thordur Oskarsson; Jacqueline D Shields
Journal:  Cancer Immunol Res       Date:  2022-04-01       Impact factor: 11.151

9.  A three-dimensional engineered heterogeneous tumor model for assessing cellular environment and response.

Authors:  Darren Rodenhizer; Teresa Dean; Bin Xu; Dan Cojocari; Alison P McGuigan
Journal:  Nat Protoc       Date:  2018-09       Impact factor: 13.491

Review 10.  Natural Compounds as Metabolic Modulators of the Tumor Microenvironment.

Authors:  Ana S Dias; Luisa Helguero; Catarina R Almeida; Iola F Duarte
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.